In addition to ZNF432, an ever-increasing number of ZFPs have been shown to impact genome stability which could eventually lead to the establishment of a predictive ZFP gene signature for PARPi response with prognostic value in ovarian cancer. The gene discussed is ZNF432; the disease is ovarian carcinoma.